Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human DLL4 ELISA Kit (AC2466)
Cat.#: ASET-1055
Specifications
Description Human DLL4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human DLL4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.82 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2025 Human HNT ELISA Kit (AC3436) Quantitative inquiry ASET-1405 Human Thimet Oligopeptidase ELISA Kit (AC2816) Quantitative inquiry ASET-1123 Rat Calbindin ELISA Kit (AC2534) Quantitative inquiry ASET-2139 Rat Neurotensin ELISA Kit (AC3550) Quantitative inquiry ASET-1579 Human CNTN5 ELISA Kit (AC2990) Quantitative inquiry ASET-1565 Human BASP1 ELISA Kit (AC2976) Quantitative inquiry ASET-2057 Monkey Adiponectin ELISA Kit (AC3468) Quantitative inquiry ASET-2289 Rat Dehydroepiandrosterone ELISA Kit (AC3700) Quantitative inquiry ASET-1832 Human NCAM1 ELISA Kit (AC3243) Quantitative inquiry ASET-2487 Mouse GDNF ELISA Kit (AC3898) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket